We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News Medica 2024 AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

AI-Assisted Technology Platform to Be Used in Hunt for Most Effective COVID-19 Treatments

By HospiMedica International staff writers
Posted on 16 Jul 2020
New tools for automated network meta-analysis are now being used in the hunt for the most effective treatments for COVID-19.

Doctor Evidence (DRE Santa Monica, CA, USA), a Software-as-a-Service (SaaS) company in the AI-enabled health technology marketplace, is offering its DOC Analytics platform for real time aggregation of all the clinical trial data that is continuously emerging.

Image: AI-Assisted Technology Platform to Be Used in Hunt for Most Effective COVID-19 Treatments (Photo courtesy of Doctor Evidence)
Image: AI-Assisted Technology Platform to Be Used in Hunt for Most Effective COVID-19 Treatments (Photo courtesy of Doctor Evidence)

Currently, about 1,798 COVID-19 treatment trials are underway across the world and preliminary results and data from high-profile trials are now available, including for Remdesivir, Dexamethasone, and Hydroxychloroquine. DRE is using its first-in-industry DOC Analytics platform to generate real-time network meta-analysis for researchers to produce quantitative analysis for any therapeutic question in the global landscape. This approach will inform decision-makers with regard to real-time updates from clinical trials for quantitative comparison, analysis, and reporting on relevant outcomes.

This novel quantitative analytic approach leverages DRE’s open DOC Search platform for COVID-19, which makes available annotated set of literature from CORD19, the open research dataset made available by the Allen Institute in response to the White House Task Force call to action in late March. DOC Search provides the foundation of medical conceptual organization to identify which key concepts are being reported across literature and trials.

“We are breaking new ground in AI-assisted technology at a critical time for healthcare,” said Bob Battista, MBA, FRCPH, FRCP Edin., Co-founder and Chief Executive Officer of DRE. “Our industry-first automated network meta-analysis technology and AI-enabled search engine are being utilized for rapid assessment of drug candidates for COVID-19. DOC Search and Analytics are being used as a foundational tool by top 10 industry ranked global pharmaceutical/life science companies that are DRE clients.”

Related Links:
Doctor Evidence


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Electric Cast Saw
CC4 System
New
Medical-Grade POC Terminal
POC-821

Latest COVID-19 News

Low-Cost System Detects SARS-CoV-2 Virus in Hospital Air Using High-Tech Bubbles

World's First Inhalable COVID-19 Vaccine Approved in China

COVID-19 Vaccine Patch Fights SARS-CoV-2 Variants Better than Needles